Daniel Bright

Dan is an experienced Program Manager and Manufacturing Operations professional with deep experience and technical expertise in the CGT space.  He has worked, built, and managed facilities, people, and portfolios across a variety of organizational types and sizes, including time spent with both CDMO and Sponsor-side organizations.

Prior to joining Dark Horse Consulting Group, Dan worked as a Global Program Manager and technical SME at Ferring Pharmaceuticals, taking on roles of increasing scope, accountability, and impact as the company built and commercialized a new portfolio and global footprint in the CGT space. His time spent here included active management of and engagement with a  variety of regulatory agencies and geographies across the globe, as well as providing focused SME support to due diligence and investment activities related to advanced therapies across the wider portfolio of Ferring companies.

Before Ferring, Dan worked at Cellectis S.A., joining in May 2020 in the role of Director of Manufacturing. During his time here he was responsible for building a team and all related processes and systems for the organization's first directly owned, fully dedicated GMP manufacturing facility. His work here focused on a multi-phase design, build, and qualification of a site intended to ultimately produce commercial CGT products and critical precursors like viral vector, mRNA, and plasmids from a single integrated site.

Before joining Cellectis, he worked at Hitachi Chemical Advanced Therapeutic Solutions (HCATS, now known as Minaris Regenerative Medicine), a US based CDMO organization with an international, multi-site footprint. He worked out of the HQ site in the US where he was the Director of Operations for the organization and was additionally accountable for the Project Management team, the OTJ Training group, a team of Compliance Investigators, and the Aseptic Sanitization personnel and processes for the facilities at the NJ site.

Prior to this Dan worked in Program and Project Management at HCATS and had previously held Project and Account Management roles within other organizations both internal and external to the Pharmaceutical field.

Ferring Pharmacueticals
Ex-US Technical Launch Lead (Global Gene Therapeutics)
External Capacity Expansion Lead (Global Gene Therapeutics)
US Commercial Tech Transfer Lead (Global Adstiladrin Program)
Senior Global Project Manager (Gene Therapy Manufacturing Launch)

Cellectis
Director of Manufacturing Operation

Hitachi Chemical Advanced Therapeutic Solutions
Director of Operations
Senior Project Manager

• William Paterson University of New Jersey, BA